发明名称 |
High Avidity Antigen Recognizing Constructs |
摘要 |
The present invention pertains to novel high avidity antigen recognizing constructs, such as antibodies or T cell receptors, which specifically bind to the melanoma associated antigen (MAGE) A1. The constructs of the invention are particularly useful for the diagnosis, prevention or therapy of tumorous diseases which are characterized by the specific expression of the MAGE-A1 antigen. Furthermore provided are nucleic acids, vectors and host cells—such as CD4 or CD8 positive T cells—which encode, comprise or present the antigen recognizing constructs of the invention. The invention thus provides new means for immune therapy, specifically adoptive T cell therapy, for treating cancer. |
申请公布号 |
US2015353622(A1) |
申请公布日期 |
2015.12.10 |
申请号 |
US201414763421 |
申请日期 |
2014.01.29 |
申请人 |
MAX-DELBRÜCK-CENTRUM FÜR MOLEKULARE MEDIZIN (MDC) BERLIN-BUCH |
发明人 |
BLANKENSTEIN Thomas;OBENAUS Matthias;LEITAO Catarina |
分类号 |
C07K14/725;C07K16/28;G01N33/574;C07K16/30 |
主分类号 |
C07K14/725 |
代理机构 |
|
代理人 |
|
主权项 |
1. An antigen recognizing construct comprising a complementary determining region 3 (CDR3) having at least 90% sequence identity to an amino acid sequence selected from SEQ ID NOs: 1 to 6. |
地址 |
Berlin DE |